OnCo
journalsJournal

JNCI: Journal of the National Cancer Institute

aka JNCI, J Natl Cancer Inst

JNCI began as the US National Cancer Institute's own journal and is now independent. It is strong on cancer epidemiology, screening, trial methodology and health disparities.

Founded in 1940 as the NCI's journal and now published by Oxford University Press with an independent editorial board. Publishes epidemiology and risk-factor studies, screening and surveillance research, trial-methods and trial-participation analyses (Unger's 2019 review of barriers to trial enrolment in this corpus), and the annual US 'Report to the Nation' on cancer status. Hybrid access.

Publisher
Oxford University Press
Scope
cancer epidemiology
Access model
hybrid
Founded
1940
ISSN
0027-8874

Key papers published here

1top
meta analysis2019
Unger: most patients never get the chance to join a cancer trial, and when offered, half say yes

Patients are not the bottleneck; trial access is. Bringing trials to community practices, loosening restrictive eligibility criteria and reducing site burden would do more for enrolment than patient education. Trials today reflect the minority of patients who happen to be treated where trials exist.

People

1top
Surendra Shastri
Preventive oncologist; former Head, Preventive Oncology, Tata Memorial Hospital
Cervical cancer screeningVisual inspection with acetic acidBreast and oral cancer screening

Led the Mumbai trial showing that visual inspection with acetic acid by health workers cuts cervical cancer deaths.

Connected

2top

institutions

1
National Cancer Institute (NIH)

collections

1
JNCI: Journal of the National Cancer Institute